Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05412927 · ClinicalTrials.gov registry record
AngelMed Guardian® System PMA Post Approval Study
A clinical trial of Acute Coronary Syndrome, sponsored by Angel Medical Systems.
- Recruiting
- Registry status
- 500
- Enrollment target
- 18
- Study locations
NCT05412927 is a study of Acute Coronary Syndrome that is actively recruiting participants, run by Angel Medical Systems. The registered enrollment target is 500 participants, below the 2,709-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (82% lower). The trial reports 18 study locations across 8 states.
The verdict
NCT05412927, a study of Acute Coronary Syndrome, is actively recruiting participants, sponsored by Angel Medical Systems.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 18
- Study locations
Study Summary
500 Patients (minimum) will be enrolled following commercial implant. Will be treated by their physicians using the standard of care. Standard of care for the Guardian includes an in-office initial programming visit 7-14 days following implant and every 6 months.
Conditions Studied
Interventions
- DEVICE PMA P150009 AngelMed Guardian® System
Study Locations (18)
Florida
- Clermont Ambulatory Surgical Center - Clermont
- Daytona Heart Group - Daytona Beach
- Florida Heart Rhythm Specialists - Fort Lauderdale
- Institute for Cardiovascular Research Studies, Inc. - Miami
- LEJ Medical, LLC - New Smyrna Beach
Arizona
- Phoenix Heart - Glendale
- Arizona Heart & Vascular Clinic - Glendale
- Southwest Cardiovascular Associates - Mesa
Louisiana
- Cardiovascular Associate Research - Covington
- Heart Clinic of Hammond - Hammond
- North Shore Heart and Vascular - Mandeville
California
- East Los Angeles Cardiology - Los Angeles
- Orange County Heart and Research Institute - Orange
Texas
- Texan Cardiovascular Institute - El Paso
- Medical City Hospital Forth Worth - Fort Worth
Georgia
- Northside Hospital Cardiovascular Institute - Atlanta
Michigan
- Corewell Health - Grand Rapids
Oklahoma
- South Oklahoma Heart Research - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-09-07 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05412927
The ClinicalTrials.gov registry entry for NCT05412927 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,709-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (82% lower). The listed sponsor is Angel Medical Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which PMA P150009 AngelMed Guardian® System is the first listed.
NCT05412927 reports 18 study locations spanning 8 distinct geographic areas - top geographies include Florida, Arizona, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05412927 about?
NCT05412927 is a clinical study titled "AngelMed Guardian® System PMA Post Approval Study". 500 Patients (minimum) will be enrolled following commercial implant. Will be treated by their physicians using the standard of care. Standard of care for the Guardian includes an in-office initial programming visit 7-14 days following implant and every 6 months.
What is the current status of trial NCT05412927?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-09-07. Estimated completion is 2026-12.
What conditions does trial NCT05412927 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome.
What interventions are being tested in trial NCT05412927?
The interventions under investigation include: PMA P150009 AngelMed Guardian® System (DEVICE).
Who is sponsoring clinical trial NCT05412927?
This trial is sponsored by Angel Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05412927 being conducted?
This trial has 18 study locations across Arizona, California, Florida, Georgia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
Online Tai Chi Plus Fitbit After ACS
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.